+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Riociguat Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120474
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The riociguat market is experiencing rapid evolution, shaped by innovative clinical adoption, complex supply chain dynamics, and expanding global therapeutic demand. Senior decision-makers must navigate this changing landscape as hospitals, specialty clinics, and payers reassess strategies for pulmonary hypertension management amid regulatory and economic shifts.

Market Snapshot: Riociguat Market Opportunities and Trajectory

The riociguat market continues to grow, reflecting sustained investment in pulmonary hypertension treatment and expanding indications. Recent regulatory approvals in chronic thromboembolic and pulmonary arterial hypertension, coupled with evolving label expansions, have drawn increased clinical and commercial attention. The U.S., Canada, and Western Europe maintain robust adoption, while emerging economies in Asia-Pacific and Latin America are evolving access frameworks. A diversified supply base and dynamic pricing negotiations further characterize this market’s trajectory, with real-world evidence validating both safety and long-term benefit.

Scope & Segmentation of the Riociguat Market

  • Indication: Chronic thromboembolic pulmonary hypertension, pulmonary arterial hypertension
  • Distribution Channels: Hospital pharmacies (private, public), online pharmacies (manufacturer owned, third party), retail pharmacies (chain, independent)
  • End User: Homecare (direct to patient, home health agencies), hospitals (private, public), specialty clinics (cardiology, rheumatology)
  • Patient Type: Adult (middle aged, senior, young adult), pediatric (adolescent, infant, neonatal)
  • Dosage: One mg, two point five mg, zero point five mg
  • Regions: Americas (including U.S. states such as California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina; Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland); Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: Bayer AG

Key Takeaways for Senior Decision-Makers

  • Riociguat’s first-in-class mechanism positions it as a critical adjunct to existing vasodilators, altering pulmonary hypertension management standards.
  • Regulatory flexibility—accelerated pathways, adaptive trial designs, and reliance on real-world evidence—has expanded therapeutic access and label indications globally.
  • Combination therapy protocols and digital health integration are advancing adherence and allowing for real-time functional monitoring, particularly in advanced-stage and refractory cases.
  • Cross-sector alliances are maximizing translational research, patient support, and education, with a focus on multidisciplinary management and clinical optimization.
  • Generic competition and specialty partnerships heighten competitive differentiation, ensuring consistent supply through technology transfer and diversified sourcing strategies.
  • Patient registry data and outcome-based agreements are influencing contracting practices, enabling value-based reimbursement in cost-sensitive regions.

Assessing Tariff Impact on Supply Chains and Pricing

The 2025 introduction of new U.S. tariffs on active pharmaceutical ingredients impacted riociguat manufacturers, leading to increased costs and prompting relocations to domestic facilities. This regulatory evolution pushed companies to develop innovative contracting models, such as outcome-based agreements, to maintain broad patient access. Global supply chain management shifted to favor non-tariff region sourcing, optimizing lead times and minimizing inventory risks. However, this transition also introduced greater complexity around compliance and regulatory alignment across regions.

Methodology & Data Sources

This report deploys a rigorous mixed-methods approach. Primary insights came from interviews with pulmonologists, cardiologists, payers, regulatory authorities, and patient groups. Secondary research includes analysis of peer-reviewed publications, clinical trial registries, and real-world utilization data. Analytical tools such as SWOT, Porter’s Five Forces, value chain mapping, and scenario modeling enhance strategic depth. Regional visuals and variance quantification ensure robust, actionable results.

Why This Report Matters: Actionable Insights for Strategic Advantage

  • Uncovers core drivers and risks shaping market expansion, guiding organizational forecasting, investment, and resource allocation.
  • Enables proactive planning for supply chain resilience, tariff impact mitigation, and digital health integration to support long-term therapy adherence.
  • Empowers decision-makers to optimize market access and payer negotiation by leveraging real-world data and evolving contracting models.

Conclusion

Riociguat stands at the intersection of clinical innovation, regulatory change, and strategic collaboration. Stakeholders equipped with these insights will navigate commercialization and therapy optimization with confidence, supporting improved patient outcomes in pulmonary hypertension.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging benefit-risk profile improvements of riociguat in treating pulmonary arterial hypertension
5.2. Impact of generic riociguat introductions on pricing dynamics and patient access
5.3. Clinical trial advancements exploring riociguat combination therapies in chronic thromboembolic pulmonary hypertension
5.4. Regulatory shifts influencing riociguat labeling expansions and off-label prescribing trends in cardiovascular care
5.5. Real-world evidence emerging from observational studies on long-term riociguat safety and efficacy in diverse populations
5.6. Patient adherence challenges driving digital health solutions for remote monitoring of riociguat treatment outcomes
5.7. Strategic partnerships between biotech firms and healthcare providers to optimize riociguat distribution networks
5.8. Market access dynamics shaped by health technology assessments and reimbursement policies for riociguat therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Riociguat Market, by Indication
8.1. Introduction
8.2. Chronic Thromboembolic Pulmonary Hypertension
8.3. Pulmonary Arterial Hypertension
9. Riociguat Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.2.1. Private
9.2.2. Public
9.3. Online Pharmacies
9.3.1. Manufacturer Owned
9.3.2. Third Party
9.4. Retail Pharmacies
9.4.1. Chain Pharmacies
9.4.2. Independent Pharmacies
10. Riociguat Market, by End User
10.1. Introduction
10.2. Homecare
10.2.1. Direct to Patient
10.2.2. Home Health Agencies
10.3. Hospitals
10.3.1. Private
10.3.2. Public
10.4. Specialty Clinics
10.4.1. Cardiology Clinics
10.4.2. Rheumatology Clinics
11. Riociguat Market, by Patient Type
11.1. Introduction
11.2. Adult
11.2.1. Middle Aged
11.2.2. Senior
11.2.3. Young Adult
11.3. Pediatric
11.3.1. Adolescent
11.3.2. Infant
11.3.3. Neonatal
12. Riociguat Market, by Dosage
12.1. Introduction
12.2. One Mg
12.3. Two Point Five Mg
12.4. Zero Point Five Mg
13. Americas Riociguat Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Riociguat Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Riociguat Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bayer AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RIOCIGUAT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL RIOCIGUAT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL RIOCIGUAT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL RIOCIGUAT MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL RIOCIGUAT MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RIOCIGUAT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RIOCIGUAT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES RIOCIGUAT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES RIOCIGUAT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC RIOCIGUAT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. RIOCIGUAT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. RIOCIGUAT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. RIOCIGUAT MARKET: RESEARCHAI
FIGURE 26. RIOCIGUAT MARKET: RESEARCHSTATISTICS
FIGURE 27. RIOCIGUAT MARKET: RESEARCHCONTACTS
FIGURE 28. RIOCIGUAT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. RIOCIGUAT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RIOCIGUAT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL RIOCIGUAT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL RIOCIGUAT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL RIOCIGUAT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL RIOCIGUAT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL RIOCIGUAT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL RIOCIGUAT MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL RIOCIGUAT MARKET SIZE, BY CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL RIOCIGUAT MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL RIOCIGUAT MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL RIOCIGUAT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL RIOCIGUAT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL RIOCIGUAT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL RIOCIGUAT MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL RIOCIGUAT MARKET SIZE, BY MANUFACTURER OWNED, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL RIOCIGUAT MARKET SIZE, BY MANUFACTURER OWNED, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL RIOCIGUAT MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL RIOCIGUAT MARKET SIZE, BY THIRD PARTY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL RIOCIGUAT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL RIOCIGUAT MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL RIOCIGUAT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL RIOCIGUAT MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL RIOCIGUAT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL RIOCIGUAT MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL RIOCIGUAT MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL RIOCIGUAT MARKET SIZE, BY DIRECT TO PATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL RIOCIGUAT MARKET SIZE, BY HOME HEALTH AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL RIOCIGUAT MARKET SIZE, BY HOME HEALTH AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL RIOCIGUAT MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL RIOCIGUAT MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL RIOCIGUAT MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL RIOCIGUAT MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL RIOCIGUAT MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL RIOCIGUAT MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL RIOCIGUAT MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL RIOCIGUAT MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL RIOCIGUAT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL RIOCIGUAT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL RIOCIGUAT MARKET SIZE, BY MIDDLE AGED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL RIOCIGUAT MARKET SIZE, BY MIDDLE AGED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL RIOCIGUAT MARKET SIZE, BY SENIOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL RIOCIGUAT MARKET SIZE, BY SENIOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL RIOCIGUAT MARKET SIZE, BY YOUNG ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL RIOCIGUAT MARKET SIZE, BY YOUNG ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL RIOCIGUAT MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL RIOCIGUAT MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL RIOCIGUAT MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL RIOCIGUAT MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL RIOCIGUAT MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL RIOCIGUAT MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL RIOCIGUAT MARKET SIZE, BY ONE MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL RIOCIGUAT MARKET SIZE, BY ONE MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL RIOCIGUAT MARKET SIZE, BY TWO POINT FIVE MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL RIOCIGUAT MARKET SIZE, BY TWO POINT FIVE MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL RIOCIGUAT MARKET SIZE, BY ZERO POINT FIVE MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL RIOCIGUAT MARKET SIZE, BY ZERO POINT FIVE MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS RIOCIGUAT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS RIOCIGUAT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES RIOCIGUAT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES RIOCIGUAT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. CANADA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. CANADA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 158. CANADA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 159. CANADA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 160. CANADA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 161. CANADA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 162. CANADA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 163. CANADA RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. CANADA RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. CANADA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 166. CANADA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 167. CANADA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 168. CANADA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 169. CANADA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 170. CANADA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 171. CANADA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 174. CANADA RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 175. CANADA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 176. CANADA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 177. CANADA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 178. CANADA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. MEXICO RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. MEXICO RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 184. MEXICO RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 185. MEXICO RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. MEXICO RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. MEXICO RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 188. MEXICO RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 189. MEXICO RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. MEXICO RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. MEXICO RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. MEXICO RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 200. MEXICO RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 201. MEXICO RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 202. MEXICO RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 203. MEXICO RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA RIOCIGUAT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 311. GERMANY RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. GERMANY RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. GERMANY RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. GERMANY RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. GERMANY RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 316. GERMANY RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 317. GERMANY RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 318. GERMANY RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 319. GERMANY RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 320. GERMANY RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 321. GERMANY RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. GERMANY RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. GERMANY RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 324. GERMANY RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 325. GERMANY RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 326. GERMANY RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 327. GERMANY RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 328. GERMANY RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 329. GERMANY RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 330. GERMANY RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 331. GERMANY RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 332. GERMANY RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 333. GERMANY RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 334. GERMANY RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 335. GERMANY RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 336. GERMANY RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 337. FRANCE RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 338. FRANCE RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 339. FRANCE RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 340. FRANCE RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 341. FRANCE RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 342. FRANCE RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 343. FRANCE RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 344. FRANCE RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 345. FRANCE RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 346. FRANCE RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 347. FRANCE RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. FRANCE RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. FRANCE RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 350. FRANCE RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 351. FRANCE RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 352. FRANCE RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 353. FRANCE RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
TABLE 354. FRANCE RIOCIGUAT MARKET SIZE, BY SPECIALTY CLINICS, 2025-2030 (USD MILLION)
TABLE 355. FRANCE RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 356. FRANCE RIOCIGUAT MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 357. FRANCE RIOCIGUAT MARKET SIZE, BY ADULT, 2018-2024 (USD MILLION)
TABLE 358. FRANCE RIOCIGUAT MARKET SIZE, BY ADULT, 2025-2030 (USD MILLION)
TABLE 359. FRANCE RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2018-2024 (USD MILLION)
TABLE 360. FRANCE RIOCIGUAT MARKET SIZE, BY PEDIATRIC, 2025-2030 (USD MILLION)
TABLE 361. FRANCE RIOCIGUAT MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 362. FRANCE RIOCIGUAT MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 363. RUSSIA RIOCIGUAT MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 364. RUSSIA RIOCIGUAT MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 365. RUSSIA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. RUSSIA RIOCIGUAT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. RUSSIA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 368. RUSSIA RIOCIGUAT MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 369. RUSSIA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 370. RUSSIA RIOCIGUAT MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 371. RUSSIA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 372. RUSSIA RIOCIGUAT MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 373. RUSSIA RIOCIGUAT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 374. RUSSIA RIOCIGUAT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 375. RUSSIA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2018-2024 (USD MILLION)
TABLE 376. RUSSIA RIOCIGUAT MARKET SIZE, BY HOMECARE, 2025-2030 (USD MILLION)
TABLE 377. RUSSIA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 378. RUSSIA RIOCIGUAT MARKET SIZE, BY HOSPITALS, 2025-2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Riociguat market report include:
  • Bayer AG